Who
Michael Skynner
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Bicycle Therapeutics.
In numbers
- Trades disclosed
- 48
- Buys
- 0
- Sells
- 24
- Bought
- $0
- Sold
- $431K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 May 2019
- Last trade
- 5 Oct 2026
- Last filed
- 6 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 6 Oct 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,796503 at $3.57 | filing |
| 2 Oct 2026filed 6 Oct 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $6,7391,942 at $3.47 | filing |
| 15 Jul 2026filed 17 Jul 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,293532 at $4.31 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,293532 at $4.31 | filing |
| 2 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,9381,859 at $4.27 | filing |
| 2 Jul 2026filed 7 Jul 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $7,9381,859 at $4.27 | filing |
| 6 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,651525 at $5.05 | filing |
| 6 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,651525 at $5.05 | filing |
| 2 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $9,2261,879 at $4.91 | filing |
| 2 Apr 2026filed 6 Apr 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $9,2261,879 at $4.91 | filing |
| 5 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $21K3,266 at $6.46 | filing |
| 5 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $21K3,266 at $6.46 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $21K3,045 at $6.80 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Sold | $21K3,045 at $6.80 | filing |
News
No headline names them, or the companies they trade most, lately.